Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Privia Health (PRVA) EBITDA Margin (2020 - 2026)

Privia Health has reported EBITDA Margin over the past 6 years, most recently at 2.11% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 93.0% year-over-year to 2.11%; the TTM value through Dec 2025 reached 1.65%, up 61.0%, while the annual FY2025 figure was 1.65%, 61.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 2.11% at Privia Health, down from 2.51% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 3.84% in Q1 2021 and troughed at 85.45% in Q2 2021.
  • A 5-year average of 4.16% and a median of 0.92% in 2022 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: crashed -8906bps in 2021 and later soared 8398bps in 2022.
  • Year by year, EBITDA Margin stood at 6.92% in 2021, then skyrocketed by 110bps to 0.7% in 2022, then plummeted by -44bps to 0.39% in 2023, then skyrocketed by 205bps to 1.19% in 2024, then surged by 78bps to 2.11% in 2025.
  • Business Quant data shows EBITDA Margin for PRVA at 2.11% in Q4 2025, 2.51% in Q3 2025, and 0.68% in Q2 2025.